Loading
A phase 2 trial of cemiplimab in colorectal cancer, run by John Strickler, M.D., not yet recruiting.
Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer is a phase 2, interventional study registered as NCT07224022 by John Strickler, M.D., with a registry enrolment figure of 24 participants, started 2026-10-01 and due to reach its primary completion in 2028-12-31. Interventions recorded: Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)]. Conditions listed: Colon Cancer. Primary outcome: Feasibility of treatment with cemiplimab and fianlimab before surgery; Safety of treatment with cemiplimab and fianlimab before surgery. Colorectal eligibility wording from the registry: "Histologically and/or cytologically documented adenocarcinoma of the colon". No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Cemiplimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Regeneron, Cemiplimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Regeneron, Cemiplimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/